Literature DB >> 3718472

Studies on an antineoplastic fraction from human urine. Characterization of the major protein in this fraction.

N H Sloane, W R Lynn, R M Macleod, E P Hade, R Pottathil, A P Kyriazis.   

Abstract

A fraction has been isolated from human urine which exhibits antiproliferative activity against human tumour cell lines without affecting the growth of several normal diploid cell lines or tumour cells of mouse or hamster origin. The major protein present in this fraction has been characterized and tentatively designated antineoplastic urinary protein (ANUP). An S020,W value of 3.69 S was obtained by sedimentation velocity analysis, and a subunit molecular mass of 16 300 Da was obtained by sedimentation equilibrium and by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. Centrifugation data also indicated that the protein self-associates. The amino acid analysis of ANUP was consistent with its low pI (4.2) as determined by chromatofocusing analysis. Furthermore, the amino acid composition exhibited some features similar to collagen, as shown by high levels of proline and glycine, the absence of cysteine, and the presence of low levels of hydroxyproline.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718472      PMCID: PMC1146573          DOI: 10.1042/bj2340355

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  SOME PROPERTIES OF SERUM OBTAINED FROM RABBITS IMMUNIZED WITH HUMAN URINARY ERYTHROPOIETIN.

Authors:  J C SCHOOLEY; J F GARCIA
Journal:  Blood       Date:  1965-02       Impact factor: 22.113

2.  Immunochemical studies of human urinary erythropoietin.

Authors:  J C SCHOOLEY; J F GARCIA
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

3.  The isolation and characterization of plasminogen activators (urokinase) from human urine.

Authors:  W F White; G H Barlow; M M Mozen
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Antitumor effects of a normal human serum factor (normal human globulin fraction 1) on human tumor cells in vitro.

Authors:  H J Wanebo; S Green; D Marshall; R C Pace
Journal:  J Natl Cancer Inst       Date:  1984-03       Impact factor: 13.506

7.  The biochemistry of complement.

Authors:  R R Porter; K B Reid
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

8.  Lymphotoxin: an anticarcinogenic lymphokine as measured by inhibition of chemical carcinogen or ultraviolet-irradiation-induced transformation of Syrian hamster cells.

Authors:  C H Evans; J A DiPaolo
Journal:  Int J Cancer       Date:  1981-01-15       Impact factor: 7.396

9.  Purification of erythropoietin.

Authors:  E Goldwasser; C K Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon.

Authors:  J H Ransom; C H Evans; R P McCabe; N Pomato; J A Heinbaugh; M Chin; M G Hanna
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

View more
  2 in total

1.  Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily.

Authors:  K Adermann; F Wattler; S Wattler; G Heine; M Meyer; W G Forssmann; M Nehls
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Valentin Galitovskiy; Jing Qian; Sergei A Grando
Journal:  Am J Physiol Cell Physiol       Date:  2010-07-21       Impact factor: 4.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.